The Additional Nuclear Medicine System market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Additional Nuclear Medicine System market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Additional Nuclear Medicine System market.
Key players in the global Additional Nuclear Medicine System market covered in Chapter 2 and Chapter 6:
Nordion
NTP Radioisotopes
Lantheus Medical Imaging
JSC Isotope
Global Medical Solutions
GE Healthcare
Isotopia Molecular Imaging Limited
PharmaLogic
NorthStar Medical Radioisotopes
Curium
Bracco Imaging
Sinotau Pharmaceuticals
Eczac?ba??-Monrol Nuclear Products
Cardinal Health
Institute of Isotopes Co., Ltd
Bayer AG
Jubilant DraxImage
SHINE Medical Technologies
Eckert & Ziegler
Advanced Accelerator Applications
In Chapter 8 and Chapter 10.3, based on types, the Additional Nuclear Medicine System market from 2017 to 2029 is primarily split into:
G-Scan Brio
O-Scan
S-Scan
In Chapter 9 and Chapter 10.4, based on applications, the Additional Nuclear Medicine System market from 2017 to 2029 covers:
Hospital
Healthy
Diagnosis
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Additional Nuclear Medicine System market, containing global revenue and CAGR. The forecast and analysis of Additional Nuclear Medicine System market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Additional Nuclear Medicine System. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Additional Nuclear Medicine System industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Additional Nuclear Medicine System industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Additional Nuclear Medicine System in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Additional Nuclear Medicine System market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Additional Nuclear Medicine System, by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Additional Nuclear Medicine System market, including the global sales and revenue forecast, regional forecast. It also foresees the Additional Nuclear Medicine System market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Additional Nuclear Medicine System Market Overview
1.1 Product Overview and Scope of Additional Nuclear Medicine System
1.2 Additional Nuclear Medicine System Segment by Type
1.2.1 Global Additional Nuclear Medicine System Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of G-Scan Brio
1.2.3 The Market Profile of O-Scan
1.2.4 The Market Profile of S-Scan
1.3 Global Additional Nuclear Medicine System Segment by Application
1.3.1 Additional Nuclear Medicine System Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Hospital
1.3.3 The Market Profile of Healthy
1.3.4 The Market Profile of Diagnosis
1.4 Global Additional Nuclear Medicine System Market, Region Wise (2017-2022)
1.4.1 Global Additional Nuclear Medicine System Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.3 Europe Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.3.1 Germany Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.3.2 UK Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.3.3 France Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.3.4 Italy Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.3.5 Spain Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.3.6 Russia Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.3.7 Poland Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.4 China Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.5 Japan Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.6 India Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.8 Latin America Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Additional Nuclear Medicine System Market Status and Prospect (2017-2022)
1.5 Global Market Size of Additional Nuclear Medicine System (2017-2029)
1.5.1 Global Additional Nuclear Medicine System Revenue Status and Outlook (2017-2029)
1.5.2 Global Additional Nuclear Medicine System Sales Status and Outlook (2017-2029)
2 Global Additional Nuclear Medicine System Market Landscape by Player
2.1 Global Additional Nuclear Medicine System Sales and Share by Player (2017-2022)
2.2 Global Additional Nuclear Medicine System Revenue and Market Share by Player (2017-2022)
2.3 Global Additional Nuclear Medicine System Average Price by Player (2017-2022)
2.4 Global Additional Nuclear Medicine System Gross Margin by Player (2017-2022)
2.5 Additional Nuclear Medicine System Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Additional Nuclear Medicine System Market Competitive Situation and Trends
2.6.1 Additional Nuclear Medicine System Market Concentration Rate
2.6.2 Additional Nuclear Medicine System Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Additional Nuclear Medicine System Upstream and Downstream Analysis
3.1 Additional Nuclear Medicine System Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Additional Nuclear Medicine System Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Additional Nuclear Medicine System Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Additional Nuclear Medicine System Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Additional Nuclear Medicine System
5.3.2 Increased Demand in Emerging Markets
5.4 Additional Nuclear Medicine System Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Additional Nuclear Medicine System Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Nordion
6.1.1 Nordion Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.1.3 Nordion Additional Nuclear Medicine System Market Performance (2017-2022)
6.1.4 Nordion Business Overview
6.2 NTP Radioisotopes
6.2.1 NTP Radioisotopes Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.2.3 NTP Radioisotopes Additional Nuclear Medicine System Market Performance (2017-2022)
6.2.4 NTP Radioisotopes Business Overview
6.3 Lantheus Medical Imaging
6.3.1 Lantheus Medical Imaging Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.3.3 Lantheus Medical Imaging Additional Nuclear Medicine System Market Performance (2017-2022)
6.3.4 Lantheus Medical Imaging Business Overview
6.4 JSC Isotope
6.4.1 JSC Isotope Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.4.3 JSC Isotope Additional Nuclear Medicine System Market Performance (2017-2022)
6.4.4 JSC Isotope Business Overview
6.5 Global Medical Solutions
6.5.1 Global Medical Solutions Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.5.3 Global Medical Solutions Additional Nuclear Medicine System Market Performance (2017-2022)
6.5.4 Global Medical Solutions Business Overview
6.6 GE Healthcare
6.6.1 GE Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.6.3 GE Healthcare Additional Nuclear Medicine System Market Performance (2017-2022)
6.6.4 GE Healthcare Business Overview
6.7 Isotopia Molecular Imaging Limited
6.7.1 Isotopia Molecular Imaging Limited Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.7.3 Isotopia Molecular Imaging Limited Additional Nuclear Medicine System Market Performance (2017-2022)
6.7.4 Isotopia Molecular Imaging Limited Business Overview
6.8 PharmaLogic
6.8.1 PharmaLogic Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.8.3 PharmaLogic Additional Nuclear Medicine System Market Performance (2017-2022)
6.8.4 PharmaLogic Business Overview
6.9 NorthStar Medical Radioisotopes
6.9.1 NorthStar Medical Radioisotopes Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.9.3 NorthStar Medical Radioisotopes Additional Nuclear Medicine System Market Performance (2017-2022)
6.9.4 NorthStar Medical Radioisotopes Business Overview
6.10 Curium
6.10.1 Curium Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.10.3 Curium Additional Nuclear Medicine System Market Performance (2017-2022)
6.10.4 Curium Business Overview
6.11 Bracco Imaging
6.11.1 Bracco Imaging Basic Information, Manufacturing Base, Sales Area and Competitors
6.11.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.11.3 Bracco Imaging Additional Nuclear Medicine System Market Performance (2017-2022)
6.11.4 Bracco Imaging Business Overview
6.12 Sinotau Pharmaceuticals
6.12.1 Sinotau Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
6.12.2 Additional Nuclear Medicine System Product Profiles, Application and Specification
6.12.3 Sinotau Pharmaceuticals Additional Nuclear Medicine System Market Performance (2017-2022)
6.12.4 Sinotau Pharmaceuticals Business Overview
6.13 Eczac